Hi DJ - the actual blinded trial for results, I agree.
However, I would've thought if there were any serious issues arising - moreso related to health and staiblity of the patients, severe reactions, sideaffects, etc - they would terminate early (blinded trial or not) so as to avoid unecessary pain and complications...not to be confused with effacacy.
IMO - although this doesnt indicate the trial is a success or not (yet), to me it however does inducate there are no major showstoppers, and the detail that results from the blinded trial will tell-all.
Ann: Neuren provides update on Fragile X and INTREPID trials, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.89 |
Change
-0.070(0.54%) |
Mkt cap ! $1.612B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.02 | $12.70 | $798.4K | 62.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 150 | $12.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.89 | 224 | 6 |
View Market Depth
| Last trade - 10.37am 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |